Encompass Health Capital Expenditures (CapEx) Growth & History (EHC)
Encompass Health's capital expenditures (capex) was $736.4M for fiscal 2025.
View full Encompass Health company overviewEncompass Health annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | $736.4M | $93.9M | +14.61% |
| 2024 | 2024-12-31 | $642.5M | $59.4M | +10.19% |
| 2023 | 2023-12-31 | $583.1M | $18.3M | +3.24% |
| 2022 | 2022-12-31 | $564.8M | $40.2M | +7.66% |
| 2021 | 2021-12-31 | $524.6M | $131.8M | +33.55% |
| 2020 | 2020-12-31 | $392.8M | $20.4M | +5.48% |
| 2019 | 2019-12-31 | $372.4M | $117.9M | +46.33% |
| 2018 | 2018-12-31 | $254.5M | $28.7M | +12.71% |
| 2017 | 2017-12-31 | $225.8M | $48.1M | +27.07% |
| 2016 | 2016-12-31 | $177.7M | $49.3M | +38.40% |
| 2015 | 2015-12-31 | $128.4M | −$42.5M | −24.87% |
| 2014 | 2014-12-31 | $170.9M | −$24.3M | −12.45% |
| 2013 | 2013-12-31 | $195.2M | $54.4M | +38.64% |
| 2012 | 2012-12-31 | $140.8M | $40.5M | +40.38% |
| 2011 | 2011-12-31 | $100.3M | $37.5M | +59.71% |
| 2010 | 2010-12-31 | $62.8M | −$500,000 | −0.79% |
| 2009 | 2009-12-31 | $63.3M | $7.6M | +13.64% |
| 2008 | 2008-12-31 | $55.7M | — | — |
Encompass Health quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $220.3M | $63.4M | +40.41% |
| Q1 2026 · Mar 31 | 2026-03-31 | $162.4M | −$700,000 | −0.43% |
| Q4 2025 | 2025-12-31 | $229.3M | $30.6M | +15.40% |
| Q1 2026 · Sep 30 | 2025-09-30 | $187.1M | $39.6M | +26.85% |
| Q2 2025 | 2025-06-30 | $156.9M | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $163.1M | $23.7M | +17.00% |
| Q4 2024 | 2024-12-31 | $198.7M | −$23.9M | −10.74% |
| Q3 2024 | 2024-09-30 | $147.5M | $800,000 | +0.55% |
| Q2 2024 | 2024-06-30 | $156.9M | $39.7M | +33.87% |
| Q1 2024 | 2024-03-31 | $139.4M | $42.8M | +44.31% |
| Q4 2023 | 2023-12-31 | $222.6M | $32.7M | +17.22% |
| Q3 2023 | 2023-09-30 | $146.7M | −$2.6M | −1.74% |
| Q2 2023 | 2023-06-30 | $117.2M | $4.5M | +3.99% |
| Q1 2023 | 2023-03-31 | $96.6M | −$16.3M | −14.44% |
| Q4 2022 | 2022-12-31 | $189.9M | −$2.4M | −1.25% |
| Q3 2022 | 2022-09-30 | $149.3M | $29.7M | +24.83% |
| Q2 2022 | 2022-06-30 | $112.7M | −$1.2M | −1.05% |
| Q1 2022 | 2022-03-31 | $112.9M | $14.1M | +14.27% |
| Q4 2021 | 2021-12-31 | $192.3M | $55.7M | +40.78% |
| Q3 2021 | 2021-09-30 | $119.6M | $30.0M | +33.48% |
| Q2 2021 | 2021-06-30 | $113.9M | $30.8M | +37.06% |
| Q1 2021 | 2021-03-31 | $98.8M | $15.3M | +18.32% |
| Q4 2020 | 2020-12-31 | $136.6M | $24.1M | +21.42% |
| Q3 2020 | 2020-09-30 | $89.6M | −$14.5M | −13.93% |
| Q2 2020 | 2020-06-30 | $83.1M | −$400,000 | −0.48% |
| Q1 2020 | 2020-03-31 | $83.5M | $11.2M | +15.49% |
| Q4 2019 | 2019-12-31 | $112.5M | $29.5M | +35.54% |
| Q3 2019 | 2019-09-30 | $104.1M | $41.4M | +66.03% |
| Q2 2019 | 2019-06-30 | $83.5M | $34.6M | +70.76% |
| Q1 2019 | 2019-03-31 | $72.3M | $12.4M | +20.70% |
| Q4 2018 | 2018-12-31 | $83.0M | — | — |
| Q3 2018 | 2018-09-30 | $62.7M | $6.9M | +12.37% |
| Q2 2018 | 2018-06-30 | $48.9M | −$9.8M | −16.70% |
| Q1 2018 | 2018-03-31 | $59.9M | $18.7M | +45.39% |
| Q3 2017 · Sep 30 | 2017-09-30 | $55.8M | $13.3M | +31.29% |
| Q2 2017 · Jun 30 | 2017-06-30 | $58.7M | $18.7M | +46.75% |
| Q1 2017 | 2017-03-31 | $41.2M | $9.8M | +31.21% |
| Q4 2016 | 2016-12-31 | $63.8M | — | — |
| Q3 2016 | 2016-09-30 | $42.5M | $3.6M | +9.25% |
| Q2 2016 | 2016-06-30 | $40.0M | $11.4M | +39.86% |
| Q1 2016 | 2016-03-31 | $31.4M | $13.7M | +77.40% |
| Q3 2015 · Sep 30 | 2015-09-30 | $38.9M | −$5.5M | −12.39% |
| Q2 2015 | 2015-06-30 | $28.6M | −$4.3M | −13.07% |
| Q1 2015 | 2015-03-31 | $17.7M | −$38.9M | −68.73% |
| Q3 2014 · Sep 30 | 2014-09-30 | $44.4M | −$53.4M | −54.60% |
| Q2 2014 · Jun 30 | 2014-06-30 | $32.9M | −$6.0M | −15.42% |
| Q1 2014 | 2014-03-31 | $56.6M | $26.5M | +88.04% |
| Q4 2013 | 2013-12-31 | $28.4M | $100,000 | +0.35% |
| Q3 2013 | 2013-09-30 | $97.8M | $68.1M | +229.29% |
| Q2 2013 | 2013-06-30 | $38.9M | −$16.7M | −30.04% |
| Q1 2013 | 2013-03-31 | $30.1M | $2.9M | +10.66% |
| Q4 2012 | 2012-12-31 | $28.3M | −$16.1M | −36.26% |
| Q3 2012 | 2012-09-30 | $29.7M | $5.5M | +22.73% |
| Q2 2012 | 2012-06-30 | $55.6M | $36.9M | +197.33% |
| Q1 2012 | 2012-03-31 | $27.2M | $14.2M | +109.23% |
| Q4 2011 | 2011-12-31 | $44.4M | $30.4M | +217.14% |
| Q3 2011 | 2011-09-30 | $24.2M | $4.5M | +22.84% |
| Q2 2011 | 2011-06-30 | $18.7M | $3.6M | +23.84% |
| Q1 2011 | 2011-03-31 | $13.0M | −$1.0M | −7.14% |
| Q4 2010 | 2010-12-31 | $14.0M | — | — |
| Q3 2010 | 2010-09-30 | $19.7M | −$100,000 | −0.51% |
| Q2 2010 | 2010-06-30 | $15.1M | — | — |
| Q1 2010 | 2010-03-31 | $14.0M | — | — |
| Q3 2009 | 2009-09-30 | $19.8M | — | — |
Encompass Health capital expenditures (capex) trends
Over the last five fiscal years, Encompass Health's capital expenditures (capex) increased from $392.8M to $736.4M, a change of $343.6M. The latest reported quarter, Q2 2026, shows $220.3M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Encompass Health source filings ↗